Full Text View
Tabular View
No Study Results Posted
Related Studies
Melphalan in Patients With Neoplastic Meningitis
This study is ongoing, but not recruiting participants.
Study NCT00002750   Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999   Last Updated: July 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Extragonadal Germ Cell Tumor
Leukemia
Lymphoma
Metastatic Cancer
Ovarian Cancer
Additional conditions recognized in this trial
Central Nervous System Neoplasms
Meningitis
Neoplasm Metastasis
Neoplasms, Germ Cell and Embryonal
Nervous System Neoplasms
Ovarian Neoplasms
More general conditions related to this trial
Adnexal Diseases
Central Nervous System Diseases
Central Nervous System Infections
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplastic Processes
Nervous System Diseases
Ovarian Diseases
Pathologic Processes
Urogenital Neoplasms
Interventions listed in this trial
melphalan
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Duke University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services